The Maryland Innovation Initiative (MII) has awarded $22 million to more than 200 commercialization projects to include 46 start-up companies since its inception in late 2012.
Oncology Times: Novel Prodrugs of 6-Diazo-5-Oxo-L-Norleucine With More Brain Delivery
Click here to read more
Johns Hopkins Scientists Track Metabolic Pathways to Find Drug Combination for Pancreatic Cancer.
Since 2009, the Johns Hopkins Drug Discovery program has provided the Johns Hopkins community with core expertise in drug discovery research including medicinal chemistry, screening assay development, drug metabolism and pharmacokinetics, and animal pharmacology/toxicology. The Johns Hopkins Drug Discovery Program, located in Baltimore, MD, works with the researchers across Johns Hopkins to research and develop tomorrow’s therapeutics for a wide range of human disorders.